# A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients

> **NCT01202084** · PHASE3 · COMPLETED · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 222 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Formoterol/Fluticasone
- **DRUG:** Foraseq®
- **DRUG:** Fluticasone

## Key facts

- **NCT ID:** NCT01202084
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2015-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202084, "A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01202084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*